Table 3.
The distribution of genders in 757 asymptomatic patients.
| Types | Total | Male | Female | p | |||
|---|---|---|---|---|---|---|---|
| N | Proportion (%) | N | Proportion (%) | N | Proportion (%) | ||
| Total | 757 | 100.00% | 146 | 19.29% | 611 | 80.71% | <0.0001 |
| Pathogens | 799 | 100.00% | 147 | 18.40% | 652 | 81.60% | <0.0001 |
| UU | 683 | 85.48% | 133 | 90.48% | 550 | 84.36% | 0.0571 |
| CT | 94 | 11.76% | 14 | 9.52% | 80 | 12.27% | 0.3506 |
| NG | 22 | 2.75% | 0 | 0.00% | 22 | 3.37% | 0.0239 |
| Infection types | |||||||
| Single | 715 | 94.45% | 145 | 99.32% | 570 | 93.29% | 0.0043 |
| UU | 643 | 84.94% | 132 | 90.41% | 511 | 83.63% | 0.0397 |
| CT | 58 | 7.66% | 13 | 8.90% | 45 | 7.36% | 0.5299 |
| NG | 14 | 1.85% | 0 | 0.00% | 14 | 2.29% | 0.0843 |
| Double | 39 | 5.15% | 1 | 0.68% | 38 | 6.22% | 0.0066 |
| UU+CT | 34 | 4.49% | 1 | 0.68% | 33 | 5.40% | 0.0134 |
| UU+NG | 3 | 0.40% | 0 | 0.00% | 3 | 0.49% | 1.0000 |
| CT+NG | 2 | 0.26% | 0 | 0.00% | 2 | 0.33% | 1.0000 |
| Triple | 3 | 0.40% | 0 | 0.00% | 3 | 0.49% | 1.0000 |
| Age groups | |||||||
| ≤ 20 | 16 | 2.11% | 2 | 1.37% | 14 | 2.29% | 0.7495 |
| 21–30 | 321 | 42.40% | 63 | 43.15% | 258 | 42.23% | 0.8390 |
| 31–40 | 293 | 38.71% | 66 | 45.21% | 227 | 37.15% | 0.0727 |
| 41–50 | 78 | 10.30% | 5 | 3.42% | 73 | 11.95% | 0.0023 |
| 51–60 | 33 | 4.36% | 1 | 0.68% | 32 | 5.24% | 0.0155 |
| >60 | 16 | 0.02114 | 9 | 6.16% | 7 | 1.15% | 0.0010 |